3h
TipRanks on MSNIonis Pharmaceuticals initiated with a Buy at H.C. WainwrightH.C. Wainwright initiated coverage of Ionis Pharmaceuticals (IONS) with a Buy rating and $45 price target Ionis is a commercial-stage biotech ...
About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results